This was the stock's second consecutive day of losses.

JPMorgan lowered the firm’s price target on Regeneron (REGN) to $1,000 from $1,100 and keeps an Overweight rating on the shares. The firm ...

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...

作为 Regeneron 制药公司的首席信息官已有六年，Bob McCowan 从内部晋升到这个职位，这让他能够以对基础设施运作的深入了解来处理这个全方位的职位。他说：" 我们启动了一个全面的现代化计划，作为 CIO，我能够接手并推进这个计划。Regeneron ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...

2025年3月，和铂医药与阿斯利康的全球合作引发行业震动：1.75亿美元首付款、最高44亿美元里程碑、9.15%股权溢价37%认购，叠加北京共建创新中心，这一交易结构直指再生元（Regeneron）与赛诺菲的经典范式——以技术平台为核，以股权绑定为锚 ...

Adds Regeneron comment Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 1.6% after the company's loss against Amgen (NASDAQ:AMGN) in a patent case over Regeneron's blockbuster Eylea drug was affirmed ...

在美国历史最悠久且最具声望的科学与数学竞赛——2025年Regeneron科学人才搜索（Regeneron Science Talent Search）上，总计超过180万美元的奖金被颁发给高中毕业生，表彰他们在天文分类、罕见肌肉疾病治疗及长期数学问题解决方面的创新研究。此次获奖的首位幸运儿是来自加利福尼亚圣盖博谷的18岁学生Matteo ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other blue chip stocks to invest in at 52-week lows. For the first time since ...

Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...